AVM to present at FIRM (Forum for Innovative Regenerative Medicine)

Tuesday October 11 2016

AVM Biotechnology was chosen as one of 6 biotech companies invited to Japan to present to the Forum for Innovative Regenerative Medicine (FIRM).

Below is presentation summary from Dr. Theresa Deisher, Founder and CEO of AVM Biotechnology

Add Your Comment

Your email address will not be published. Required fields are marked *